Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
ROS-Driven Metabolic Rewiring in BRAF Inhibitor-Treated Mela
2026-06-10
Cesi et al. (2017) demonstrate that BRAF inhibitor therapy in melanoma cells elevates reactive oxygen species (ROS), activating pyruvate dehydrogenase kinases (PDKs) and altering central metabolism. This mechanistic insight reveals a metabolic vulnerability in drug-resistant melanoma and supports PDK inhibition as a promising therapeutic strategy.
-
PPP1R3G/PP1γ-Mediated RIPK1 Dephosphorylation Drives Cell De
2026-06-09
This study uncovers how the phosphatase complex PPP1R3G/PP1γ dephosphorylates RIPK1 to promote apoptosis and necroptosis, clarifying a longstanding gap in understanding cell death regulation. These mechanistic insights have direct implications for inflammation and cancer biology research, where precise modulation of NF-κB and RIPK1 pathways is pivotal.
-
5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate
2026-06-09
This article provides a scenario-driven, evidence-based analysis of how 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate), SKU B8113, addresses laboratory challenges in epigenetic DNA modification research. Bench scientists and postgraduate researchers will benefit from practical Q&A, protocol guidance, and literature-backed recommendations for reliable gene expression and plant drought response studies.
-
Cy5 Maleimide: Advancing Protein Imaging & Condensate Biolog
2026-06-08
This thought-leadership article bridges the gap between mechanistic insight and strategic guidance for translational researchers employing Cy5 maleimide (non-sulfonated) in protein labeling. Drawing upon current advances in protein phase separation and molecular partitioning, it contextualizes the role of thiol-reactive fluorescent dyes in probing electrostatic landscapes within biomolecular condensates—delivering actionable recommendations for translational workflows.
-
Cy5 amine (non-sulfonated): Protocols, QC, and Troubleshooti
2026-06-08
Cy5 amine (non-sulfonated) is a bright, photostable fluorescent probe with a primary amino group, tailored for workflows needing water-insoluble labeling reagents. It is best suited for labeling proteins, peptides, and polymers in fluorescence microscopy and flow cytometry, but should not be used for direct aqueous labeling or clinical diagnostics.
-
Cy5 Maleimide: Precision Fluorescent Labeling in Biomolecule
2026-06-07
Cy5 maleimide (non-sulfonated) empowers protein and peptide labeling workflows with high site-selectivity and robust detection in advanced fluorescence assays. Its unique reactivity and photophysical properties make it the dye of choice for dissecting protein partitioning in cellular condensates and beyond.
-
Sulfo-Cy3 NHS Ester (SKU A8107): Reliable Fluorescent Protei
2026-06-06
This evidence-based guide explores how Sulfo-Cy3 NHS ester (SKU A8107) overcomes common challenges in fluorescent labeling of proteins and peptides for cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed research and best practices, the article demonstrates the product's value as a highly water-soluble, hydrophilic fluorescent dye, supporting reproducible results in demanding biomedical workflows.
-
Mechanistic Leverage: Dual-Reporter mRNA for Translational R
2026-06-05
This article unpacks the strategic and mechanistic advantages of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) for translational researchers. By integrating dual-reporter detection, immune evasion, and superior stability features, we explore how this tool transforms mRNA delivery and in vivo imaging workflows—while critically benchmarking its performance against emerging non-viral vectors and industry standards. The discussion bridges recent literature on metal-organic frameworks and protein corona effects, and provides actionable guidance on protocol parameters, experimental design, and future directions for robust, clinically relevant mRNA research.
-
Central Circuits Controlling Opioid-Induced Mechanical Hyper
2026-06-05
Yin et al. (2024) identified a brain-to-spinal neural pathway that governs opioid-induced mechanical hypersensitivity and analgesic tolerance in mice. Their work clarifies the specific neuronal circuitry underlying these phenomena, providing a foundation for targeted interventions in chronic pain and opioid tolerance research.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Dual-Mode Tracking and A
2026-06-04
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) empowers gene expression and intracellular tracking with simultaneous fluorescence and bioluminescence readouts. Its advanced Cap1 structure and 5-moUTP modifications boost translation efficiency and minimize immune activation, streamlining workflows in mRNA delivery optimization and in vivo imaging.
-
Hydroxycinnamic Acids Modulate COPII-STING to Suppress Infla
2026-06-04
This study uncovers the molecular mechanism by which hydroxycinnamic acids (HCAs) directly target the Sec24 B-site of the COPII complex, disrupting STING trafficking and attenuating inflammation and metabolic dysfunction in type 2 diabetes models. These findings establish a mechanistic bridge between traditional Chinese medicine bioactives and the regulation of innate immune signaling, with implications for diseases involving cGAS-STING hyperactivation.
-
Amikacin (BAY416651): Innovations in Targeted Antibiotic Res
2026-06-03
Explore Amikacin (BAY416651) as a bacterial protein synthesis inhibitor, with a focus on novel targeted delivery methods and resistance mechanisms. Uncover practical assay insights and research applications that advance antibiotic resistance studies.
-
Acetylation-Regulated Spliceosome Alters PARP Inhibitor Sens
2026-06-03
This study uncovers the pivotal role of SmD2 acetylation in modulating DNA repair and response to PARP inhibitors in hepatocellular carcinoma (HCC). The findings suggest that targeting spliceosome regulation and protein acetylation could broaden therapeutic options, especially for BRCA1/2-proficient HCC.
-
E-4031: hERG Potassium Channel Blocker in Cardiac Research
2026-06-02
E-4031 is the gold-standard hERG potassium channel blocker for modeling proarrhythmic substrates, QT interval prolongation, and torsades de pointes (TdP) in cardiac electrophysiology research. Explore best-practice protocols, troubleshooting, and how APExBIO’s high-purity E-4031 advances assay reproducibility and translational insight.
-
Cy5-UTP in RNA Labeling: Protocols, Use-Cases & Innovations
2026-06-02
Cy5-UTP (Cyanine 5-UTP) transforms RNA labeling workflows by enabling direct, high-sensitivity probe visualization and precise multiplexing. This guide translates reference-driven insights and bench-tested protocol enhancements into actionable steps for molecular biologists tackling advanced RNA analysis.